Congenital small ears
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Bladder Neoplasm
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
|
14517837 |
2003 |
Carcinoma of bladder
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
|
14517837 |
2003 |
Malignant neoplasm of prostate
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
WIF1 was down-regulated in 64% of primary prostate cancers, while SFRP4 was up-regulated in 81% of the patients.
|
14517837 |
2003 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells.
|
15019166 |
2004 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Wif-1, a putative tumor suppressor, is a soluble negative regulator of the Wnt pathway activated in CLL.
|
16427695 |
2006 |
Malignant Pleural Mesothelioma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
|
16516163 |
2006 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
WIF1 is an antagonist of the Wnt signaling pathway, which plays a critical role in human cancer.
|
17171686 |
2007 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
WIF1 is an antagonist of the Wnt signaling pathway, which plays a critical role in human cancer.
|
17171686 |
2007 |
Osteosarcoma
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Wif1 was highly expressed in the developing and mature mouse skeleton, and, although it was dispensable for normal development, targeted deletion of mouse Wif1 accelerated development of radiation-induced osteosarcomas in vivo.
|
19307728 |
2009 |
Breast Carcinoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
WIF1 and DKK3 promoter methylation were detected in 63.3% (95/150) and 61.3% (92/150) of breast carcinoma samples, respectively.
|
19570204 |
2009 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
WIF-1 has been described as a tumor suppressor in various types of cancer.
|
19887605 |
2009 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
WIF-1 has been described as a tumor suppressor in various types of cancer.
|
19887605 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
WIF-1 transfection significantly induced apoptosis and suppressed in vivo tumor growth.
|
19887605 |
2009 |
Liver carcinoma
|
0.060 |
PosttranslationalModification
|
disease |
BEFREE |
WIF-1 silencing as a result of its promoter hypermethylation may be a frequent event in HCC.
|
20119713 |
2010 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
|
20197388 |
2010 |
Neoplasm Metastasis
|
0.060 |
Biomarker
|
phenotype |
BEFREE |
Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
|
20197388 |
2010 |
Secondary malignant neoplasm of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
WIF-1 overexpression also markedly reduced the number of lung metastasis in vivo in an orthotopic mouse model of osteosarcoma.
|
20197388 |
2010 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
WIF-1 is a negative regulator of the Wnt-signaling pathway that may have important implications for tumorigenesis.
|
20596629 |
2010 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
WIF1 encodes a secreted Wnt antagonist and was strongly downregulated in most glioblastomas as compared with normal brain, implying deregulation of Wnt signaling, which is associated with cancer.
|
21642372 |
2011 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
WIF1 encodes a secreted Wnt antagonist and was strongly downregulated in most glioblastomas as compared with normal brain, implying deregulation of Wnt signaling, which is associated with cancer.
|
21642372 |
2011 |
Cervical Squamous Cell Carcinoma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
|
21873353 |
2011 |
Malignant tumor of cervix
|
0.020 |
Biomarker
|
disease |
BEFREE |
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
|
22002305 |
2012 |
Cervix carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
|
22002305 |
2012 |
cervical cancer
|
0.020 |
Biomarker
|
disease |
BEFREE |
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
|
22002305 |
2012 |